Entera Bio Ltd. (ENTX)
NASDAQ: ENTX
· Real-Time Price · USD
2.35
-0.06 (-2.49%)
At close: Oct 17, 2025, 3:59 PM
2.35
0.00%
After-hours: Oct 17, 2025, 07:52 PM EDT
Entera Bio Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
Revenue | 181K | n/a | 134K | 571K |
Cost of Revenue | 172K | 56K | 101K | 373K |
Gross Profit | 9K | -56K | 33K | 198K |
Operating Income | -9.59M | -8.89M | -13.02M | -12.22M |
Interest Income | 58K | 31K | 83K | n/a |
Pretax Income | -9.53M | -8.86M | -12.93M | -12.25M |
Net Income | -9.54M | -8.89M | -13.07M | -12.19M |
Selling & General & Admin | 5.09M | 4.43M | 7.25M | 5.69M |
Research & Development | 4.5M | 4.51M | 5.85M | 6.77M |
Other Expenses | n/a | n/a | -51K | -46K |
Operating Expenses | 9.59M | 8.88M | 13.05M | 12.41M |
Interest Expense | n/a | n/a | n/a | 29K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a |
Cost & Expenses | 9.77M | 8.94M | 13.15M | 12.79M |
Income Tax Expense | 14K | 29K | 137K | -59K |
Shares Outstanding (Basic) | 37.65M | 29.01M | 28.81M | 26.13M |
Shares Outstanding (Diluted) | 37.65M | 29.01M | 28.81M | 26.13M |
EPS (Basic) | -0.25 | -0.31 | -0.45 | -0.47 |
EPS (Diluted) | -0.25 | -0.31 | -0.45 | -0.47 |
EBITDA | -9.54M | -8.8M | -12.87M | -12.16M |
EBIT | -9.59M | -8.86M | -13.02M | -12.22M |
Depreciation & Amortization | 46K | 56K | 64K | 53K |
Source: Financial Modeling Prep. Financial Sources.